IVC filter placement and Bilateral Pulmonary Artery thrombolysis catheter placement Technique and Dictation

PROCEDURE: 

  1. Inferior venacavogram and IVC filter placement  
  2. Bilateral pulmonary artery infusion catheter placement

INDICATION: Submassive pulmonary embolism

DATE:

OPERATORS:

MEDICATIONS: Zofran 4 mg IV, Benadryl 50 mg IV

CONTRAST: 20 ml of Omnipaque 350

FLUOROSCOPY TIME: 9.7 minutes

FILTER TYPE: Cook Celect

ACCESS SITE: Right internal jugular vein with ultrasound

COMPLICATIONS: None

 

TECHNIQUE:

The risks, benefits, and alternatives to the procedure were explained to the patient.  The specific risks of bleeding, infection, pulmonary embolism, filter mal deployment, and filter migration were detailed and accepted. Written informed consent was obtained. 

The patient was assessed for conscious sedation but was not an adequate candidate because he was not NPO. The procedure was performed with local anesthesia. A dedicated nurse monitored heart rate, blood pressure, and oxygen saturation throughout the procedure. A time out was performed prior to procedure initiation.

The right neck was prepped and draped in sterile fashion. 

The vascular structures were ultrasonographically evaluated.   Images were stored and transferred to PACS.  Under ultrasound guidance, the right internal jugular vein was accessed with a micropuncture needle.  Vein patency and needle entry were documented.  A 0.018″ wire was placed and the needle exchanged for a 5 French dilator.

An Amplatz wire was advanced into the inferior vena cava, and the dilator exchanged for a 5 French marker pigtail catheter. Inferior venacavography was performed using nonionic contrast. This is a baseline study to define variant anatomy, caval size, location and number of renal veins, and to evaluate for ileocaval thrombus.

The Amplatz wire was replaced, and the pigtail exchanged for the Cook Celect filter delivery system.

Under direct fluoroscopic guidance, the filter was positioned and deployed. A hand injection was performed to assess filter position.

The sheath was exchanged over a guidewire for a 6 French vascular sheath. A 5 French pigtail catheter and Bentson guidewire were used to select the main pulmonary artery. Attempts were made to transduce the pulmonary artery pressure. 

The pigtail was advanced into the left lower lobe pulmonary artery. The pigtail catheter and sheath were exchanged over a Rosen guidewire for a 6 French Balkin sheath and a 5 French 90 cm x 20 cm Unifuse thrombolysis catheter. The Rosen guidewire was removed and the occlusion wire for the thrombolysis catheter was placed.

The right internal jugular vein was again punctured using identical technique described above. An image documenting needle entry was saved and stored to PACS. Using the same technique, a second UniFuse catheter was placed at the right lower lobe pulmonary artery.

Both sheaths were sutured to the skin with 2-0 Ethilon. The infusion catheters were secured to the sheaths with 3-0 Ethilon. Heparinized saline was attached to the side ports of each sheaths at 30 mL per hour. TPA was administered through each infusion catheter at 0.5 mg per hour. 

Biodiscs were placed at each puncture site and a sterile dressing was applied.

No immediate complication occurred, and the patient was discharged from the angiography suite in satisfactory condition.

 

FINDINGS:

  1. There is no ileocaval thrombus.
  2. There are single renal veins bilaterally. The IVC is normal in caliber. There is no aberrant anatomy.
  3. The filter is appropriately positioned below the lowest renal vein.
  4. The right vein is ultrasonographically patent and compresses. Needle entry was documented.  Images were stored to PACS.
  5. Both infusion catheters are appropriately positioned within the lower lobe pulmonary arteries. The infusion catheter lengths extends through the course of the main pulmonary artery to the lower lobe pulmonary arteries.

 

IMPRESSION:

  1. No evidence for ileocaval thrombus.
  2. Uneventful image guided placement of an infrarenal Cook Celect IVC filter as described.
  3. Successful placement of bilateral pulmonary artery infusion catheters for catheter directed thrombolysis of pulmonary emboli.

 

The patient will be scheduled in Dr. ____ clinic in approximately 3 months for discussion of filter removal.

Frequently Asked Questions

What is an IVC filter and why is it used?

An Inferior Vena Cava (IVC) filter is a small, metal device implanted in the IVC, a large vein in the abdomen, to prevent blood clots from traveling to the lungs. It's used primarily in patients who cannot take blood thinners or those with recurrent blood clots despite medication, aiming to reduce the risk of pulmonary embolism.

How is an IVC filter placed?

The placement involves accessing a large vein, typically the right internal jugular vein, using ultrasound guidance. A catheter is used to navigate into the IVC, where the filter is then deployed under fluoroscopic guidance. The procedure is minimally invasive and typically performed under local anesthesia, requiring careful imaging to ensure correct placement.

What are the risks associated with IVC filter placement?

Risks include bleeding, infection, and complications like filter migration or maldeployment. Though rare, there's also a risk of filter fracture or migration, which could potentially lead to further complications. Patients are informed of these risks prior to the procedure, and consent is obtained.

What is pulmonary artery thrombolysis?

Pulmonary artery thrombolysis involves using medication to dissolve blood clots in the pulmonary arteries. Catheters are placed in the arteries of the lungs to deliver thrombolytic agents like TPA directly to the site of the clot, which helps in dissolving the clot and restoring normal blood flow.

How are thrombolysis catheters placed in the pulmonary arteries?

Thrombolysis catheters are placed by accessing the pulmonary arteries using specialized catheters and guidewires. The process involves navigating through the vascular system to reach the pulmonary arteries, where the catheters are positioned to deliver medication directly to the clot. This procedure is guided by fluoroscopy for precise placement.

What medications are typically used during IVC filter placement and thrombolysis?

Medications such as Zofran and Benadryl may be used for nausea and allergic reactions, respectively. During thrombolysis, TPA (Tissue Plasminogen Activator) is commonly used to dissolve clots. Heparinized saline is also used to maintain catheter patency during the procedure.

What is the recovery process after IVC filter and thrombolysis procedures?

Recovery involves monitoring for immediate complications and ensuring the filter and catheters remain in place. Patients may be discharged if stable, but follow-up is crucial. The IVC filter may be scheduled for removal if no longer needed, typically discussed in follow-up consultations.

Why might a patient require both an IVC filter and bilateral pulmonary artery thrombolysis?

A patient with a submassive pulmonary embolism may require both treatments to manage the risk of further emboli and to actively dissolve existing clots in the pulmonary arteries. The combination can be necessary when anticoagulation alone is insufficient or contraindicated.

Still have questions?

Ask our vascular team — plain answers, no cost, no obligation. If it's about your own care, we'll connect you with a specialist.

Having fever, spreading redness, chest pain, or trouble breathing? Contact your doctor or seek emergency care now — don’t wait on a reply here.

Attorney reviewing a case? Request a board-certified medical expert →

📬 Stay Updated

Get the latest vascular education content delivered to your inbox.